Author response for "Imiquimod for the treatment of oral leukoplakia: A two‐center retrospective study"
Hervé Sroussi(Harvard University), Sook‐Bin Woo(Dana-Farber Brigham Cancer Center), Malak Al‐Hadlaq(Dana-Farber Cancer Institute), Alessandro Villa(Mario Negri Institute for Pharmacological Research), Kentaro Ikeda(Brigham and Women's Hospital), Piamkamon Vacharotayangul(Brigham and Women's Hospital), Sivappiriyai Veluppillai(University of California, San Francisco), Anette Vistoso Monreal(University of Southern California), Michele Lodolo(University of California, San Francisco), Nathaniel S. Treister(Brigham and Women's Hospital)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis
|Cancer Medicine|2017|753
Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes
|Bone Marrow Transplantation|2011|123
How we treat oral chronic graft-versus-host disease
|Blood|2012|102